Tue. Nov 29th, 2022

Fxtriangle | Market analysis | Managed trading

Fxtriangle will make Fx trading look easy.

AstraZeneca’s potential coronavirus vaccine

1 min read
Astra Zeneca

AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.

Drugmakers are racing to combat the pandemic that has now killed nearly 600,000 people. There are no approved vaccines for COVID-19, but the World Health Organization (WHO) has said AstraZeneca’s shot is one of the leading candidates.

The shot, AZD1222, is a recombinant viral vector vaccine developed by Oxford University.

It is licensed to AstraZeneca. Uses weakened version of a common-cold virus that encodes instructions for making proteins from the novel coronavirus to build immunity.

Likely to provide protection for about a year. An AZD1222 shot would cost about 2.5 euros ($2.8) per dose in Europe, according to Italy’s health ministry. AstraZeneca does not expect to profit from it during the pandemic. Costs in other regions not disclosed.

Late-stage trials are currently underway in Britain, Brazil And South Africa and are due to start in the United States. Mexico is in talks to run trials.

Data showed that the vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, with a stronger immune response in 10 people given an extra dose of the vaccine after 28 days.

Data from late-stage studies is expected by August to September.

Delivery of first dose expected between September and October. Experts predict a safe and effective vaccine could take 12-18 months to develop.

Leave a Reply

Forex trading and any instruments related to Foreign Exchange Market are Speculative and carry substantial risk of loss of either partial equity or the entire deposit amount. Leverage adds up to the risk, before considering to invest in this venture, you should first consider your financial position and may seek the help of an independent financial advisor. FXtriangle dis-recommends the usage of loan instruments to trade in this market as it can hamper financial position. Please do not invest the money that you cannot afford to lose. FXtriangle provides all its services throughout the Globe Excluding (Nigeria, British Virgin Island & the Islamic Republic of Iran) and also provides limited service in some jurisdictions where investment in Overseas markets / Fx Exchanges are prohibited by Law If you are not sure to contact us before using any of our services. FXtriangle acts as an Independent Corporate Financial Advisor and connects you to various overseas exchanges and cannot be held liable for any financial damage occurring through their side. All of our partnered institutions are regulated in various jurisdictions.FXtriangle conducts an independent background check before partnering with any institutions to fulfill your investment objectives smoothly. The usage of our Business name, Logo or any trademark in any financial forum, website, review website, complaint arena, Billboards without our written permission will attract lawsuits.